{"record":{"leader":"cx  j22     3  45","datafield":[{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":"http://catalogue.bnf.fr/ark:/12148/cb179115951"},{"code":2,"content":"BNF"},{"code":"d","content":20201216}],"tag":"033"},{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":"FRBNF179115958"},{"code":"z","content":"FRBNF17911595"},{"code":"d","content":20201216}],"tag":"035"},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"20201026afrey50      ba0"},"tag":100},{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":2},{"code":"b","content":1},{"code":"c","content":1}],"tag":106},{"ind2":" ","ind1":" ","subfield":{"code":"b","content":"rameau"},"tag":152},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":"#"},{"code":"a","content":"Essais cliniques de phase II"}],"tag":250},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":"#"},{"code":"a","content":"Essais cliniques de phase 2"}],"tag":450},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":"#"},{"code":"a","content":"Essais de phase II"}],"tag":450},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":"#"},{"code":"a","content":"Études cliniques de phase II"}],"tag":450},{"ind2":" ","ind1":" ","subfield":[{"code":7,"content":"ba0yba0y"},{"code":9,"content":"#"},{"code":"a","content":"Études de phase II"}],"tag":450},{"ind2":" ","ind1":" ","subfield":[{"code":3,"content":"031453996"},{"code":5,"content":"g|xxx"},{"code":7,"content":"ba0yba0y"},{"code":"a","content":"Essais cliniques des médicaments"}],"tag":550},{"ind2":" ","ind1":" ","subfield":[{"code":"a","content":615},{"code":2,"content":"Note de regroupement par domaine"}],"tag":686},{"ind2":0,"ind1":" ","subfield":[{"code":"a","content":"FR"},{"code":"b","content":"FR-751131015"},{"code":"c","content":20201130}],"tag":801},{"ind2":3,"ind1":" ","subfield":[{"code":"a","content":"FR"},{"code":"b","content":"Abes"},{"code":"c","content":20201216},{"code":"g","content":"AFNOR"}],"tag":801},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Pourquoi et comment randomiser un essai thérapeutique ? S. Chevret [in] Revue des maladies respiratoires, 2003, 20, 5"},"tag":810},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Récidives d'ostéosarcome et essais cliniques de phase II : quelles conclusions tirer de l'expérience passée ? / N. Omer, 2015 [thèse]"},"tag":810},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"TermSciences - http://www.termsciences.fr (2020-11-30)"},"tag":810},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Dict. pharmaceutique : pharmacologie et chimie des médicaments / Y. Landry, Y. Rival, 2007 (art. : Essais cliniques des médicaments) : études de phase II"},"tag":810},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Clinical Trial, Phase II"},"tag":822},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Essais cliniques de phase II"},"tag":950},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Essais cliniques de phase 2"},"tag":951},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Essais de phase II"},"tag":951},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Études cliniques de phase II"},"tag":951},{"ind2":" ","ind1":" ","subfield":{"code":"a","content":"Études de phase II"},"tag":951}],"controlfield":[{"tag":"001","content":249967324},{"tag":"003","content":"http://www.idref.fr/249967324"},{"tag":"004","content":20201026},{"tag":"005","content":20201216040933},{"tag":"006","content":385162101},{"tag":"007","content":1999},{"tag":"008","content":"Td8"}]}}